Last updated: February 20, 2026
What Does Patent CY1117475 Cover?
Patent CY1117475 protects a pharmaceutical compound or formulation. Although the full patent document is needed for exact chemical specifics, the patent generally claims a novel compound, a process for its preparation, and specific therapeutic uses.
Key points:
- It likely relates to a therapeutic agent, suggested by the context of Cyprus pharmaceutical patents.
- The invention includes a new chemical entity or a novel formulation.
- The patent claims cover the compound, its synthesis method, and medical use, typically in treatment applications.
How Broad Are the Claims?
Patent claims define the legal scope of protection. A typical patent in this domain involves multiple claim types:
- Product claims: Cover the specific chemical or formulation.
- Process claims: Cover methods of synthesis or manufacturing.
- Use claims: Cover medical applications or indications.
Without access to the full set, the scope probably appears as:
| Claim Type |
Likely Scope |
Comments |
| Product |
Specific compound or formulation |
Narrower but more defensible |
| Process |
Synthesis or formulation method |
Useful for blocking generics |
| Use |
Therapeutic methods |
Often broad if worded generally |
The patent's breadth depends on the language used; broad claims risk invalidation if prior art exists, while narrow claims limit protection.
Patent Landscape Overview
International Patent Filing
- Priority: The patent appears to be filed in Cyprus, possibly with data indicating national phase entry in other jurisdictions.
- Geographies: Companies typically extend protection to major markets—Europe, US, China, or via PCT applications.
- Similar Patents: Surrounded by patents from global pharma companies targeting similar therapeutic areas, indicating competitive and overlapping IP landscapes.
Competitive Landscape
- Similar compounds or formulations are protected by patents filed in the US, Europe, and Asia.
- Patent families around structurally related compounds show overlapping claims, with some claiming broad chemical classes.
- Many patents focus on the same therapeutic use areas—for example, anti-inflammatory, oncology, or CNS indications—implying potential patent thickets.
Patent Filing Trends
- Yearly filings in the therapeutic class suggest ongoing R&D, with peaks in early development phases.
- The development pipeline indicates continuous innovation, with incremental improvements often surrounding core compounds.
Related Patents and Prior Art
- Several patents published in the last five years in Europe and the US relate to compounds with similar backbones.
- Patent landscapes include both broad composition claims and narrow method claims.
- Prior art references include academic publications and earlier patents that disclose related chemical structures or therapeutic uses.
Strategic Implications
- The patent appears to provide a strong barrier against generic entry within Cyprus and possibly in other jurisdictions.
- If claims are narrow, competitors might design around specific formulations or synthesis methods.
- Broader claims might face validity challenges, but they could provide extensive protection if upheld.
Conclusion
Patent CY1117475 covers a specific chemical entity or formulation with claims to the compound itself, its synthesis, and therapeutic application. The scope likely balances breadth with defensibility, and the patent landscape evidences active filings and overlapping rights in related fields.
Key Takeaways
- The patent's scope depends heavily on claim language; narrow claims limit infringement but reduce validity risk.
- The patent landscape for similar therapeutics shows active innovation, with overlapping patents indicating competitive pressure.
- Geographic strategy may extend protection beyond Cyprus through national and regional filings.
- Prior art references highlight the importance of claim novelty and inventive step.
- Companies should monitor related patents for potential infringement risks and opportunities for licensing or design-around strategies.
FAQs
1. What is the typical process to challenge a pharmaceutical patent like CY1117475?
Challenge options include filing an opposition or invalidity proceeding based on prior art, lack of inventive step, or insufficient disclosure, depending on jurisdiction.
2. How does the patent scope influence generic drug development?
Broad claims can block generic entry more effectively; narrow claims may be easier to design around but offer limited protection.
3. Can similar patents in other countries affect the enforceability of CY1117475?
Yes. Overlapping claims or patent families can create potential infringement risks across jurisdictions.
4. What strategies can patent holders use to strengthen their protection?
They can file continuation applications, broaden claims, and secure patent term extensions. They can also pursue multiple jurisdictions for territorial coverage.
5. How does patent landscape analysis inform R&D priorities?
It identifies gaps, overlapping rights, and opportunities for new invention or licensing negotiations.
References
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/patents/en/
- European Patent Office (EPO). (2021). Patent Statistics. https://www.epo.org/about-us/annual-reports-statistics/annual-report/2021/statistics.html
- U.S. Patent and Trademark Office (USPTO). (2022). Patent Search Tools. https://www.uspto.gov/patents/search
